Additionally, the correlation analysis between cytokines (TNF-α, IL-1β, IL-6, and IL-10) and biomarkers indicated that CA and GA may be able to regulate those metabolites and metabolic pathways by regulating the structure of gut microflora in the treatment of IBD, thereby assisting in alleviating liver inflammation. The gene discussed is IL6; the disease is Hepatitis.